RSC Advances · 2023 · 26 citations · 42 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsChemical Library DesignLead Compound DesignLigand-based DesignOncology PharmacologyStructure-activity Relationship AnalysisAnticancer ActivityCancer Cell Line ModelsChemical Structure-activity RelationshipsChemical Synthesis Of AnaloguesMedicinal HeterocyclesMolecular Structure DeterminationPyrazole ChemistryPyrimidine Analogues
= 37.59 μM). The non-interactive interaction of active compound (9d) with Calf thymus DNA (Ct-DNA) has been investigated through various methods, such as UV-vis absorption, emission, cyclic voltammetry and circular dichroism. The DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical has been used to measure the antioxidant capacity of the pyrazoline derivative (9d). The outcomes showed that active analog has significant antioxidant activity. In addition, MD simulation of the EGFR tyrosine kinase protein-ligand complex was performed at a time scale of 100 ns. The MMGBSA data of ligand-protein complex are showed stable interactions up to 100 ns.
42